202 related articles for article (PubMed ID: 21609958)
1. Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery.
Galla M; Schambach A; Falk CS; Maetzig T; Kuehle J; Lange K; Zychlinski D; Heinz N; Brugman MH; Göhring G; Izsvák Z; Ivics Z; Baum C
Nucleic Acids Res; 2011 Sep; 39(16):7147-60. PubMed ID: 21609958
[TBL] [Abstract][Full Text] [Related]
2. Hybrid adeno-associated viral vectors utilizing transposase-mediated somatic integration for stable transgene expression in human cells.
Zhang W; Solanki M; Müther N; Ebel M; Wang J; Sun C; Izsvak Z; Ehrhardt A
PLoS One; 2013; 8(10):e76771. PubMed ID: 24116154
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomic integration profiling of Sleeping Beauty transposons mobilized with high efficacy from integrase-defective lentiviral vectors in primary human cells.
Moldt B; Miskey C; Staunstrup NH; Gogol-Döring A; Bak RO; Sharma N; Mátés L; Izsvák Z; Chen W; Ivics Z; Mikkelsen JG
Mol Ther; 2011 Aug; 19(8):1499-510. PubMed ID: 21468003
[TBL] [Abstract][Full Text] [Related]
4. The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor.
Jin Z; Maiti S; Huls H; Singh H; Olivares S; Mátés L; Izsvák Z; Ivics Z; Lee DA; Champlin RE; Cooper LJ
Gene Ther; 2011 Sep; 18(9):849-56. PubMed ID: 21451576
[TBL] [Abstract][Full Text] [Related]
5. An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector.
Benati D; Cocchiarella F; Recchia A
J Vis Exp; 2018 Jan; (131):. PubMed ID: 29364270
[TBL] [Abstract][Full Text] [Related]
6. Hyperactive piggyBac gene transfer in human cells and in vivo.
Doherty JE; Huye LE; Yusa K; Zhou L; Craig NL; Wilson MH
Hum Gene Ther; 2012 Mar; 23(3):311-20. PubMed ID: 21992617
[TBL] [Abstract][Full Text] [Related]
7. Exogenous mRNA delivery and bioavailability in gene transfer mediated by piggyBac transposition.
Bire S; Gosset D; Jégot G; Midoux P; Pichon C; Rouleux-Bonnin F
BMC Biotechnol; 2013 Sep; 13():75. PubMed ID: 24070093
[TBL] [Abstract][Full Text] [Related]
8. Sleeping Beauty transposase structure allows rational design of hyperactive variants for genetic engineering.
Voigt F; Wiedemann L; Zuliani C; Querques I; Sebe A; Mátés L; Izsvák Z; Ivics Z; Barabas O
Nat Commun; 2016 Mar; 7():11126. PubMed ID: 27025571
[TBL] [Abstract][Full Text] [Related]
9. Construction and Quantitative Evaluation of a Tissue-Specific Sleeping Beauty by EDL2-Specific Transposase Expression in Esophageal Squamous Carcinoma Cell Line KYSE-30.
Mahmoudian RA; Fathi F; Farshchian M; Abbaszadegan MR
Mol Biotechnol; 2023 Mar; 65(3):350-360. PubMed ID: 35474410
[TBL] [Abstract][Full Text] [Related]
10. Counterselection and co-delivery of transposon and transposase functions for Sleeping Beauty-mediated transposition in cultured mammalian cells.
Converse AD; Belur LR; Gori JL; Liu G; Amaya F; Aguilar-Cordova E; Hackett PB; McIvor RS
Biosci Rep; 2004 Dec; 24(6):577-94. PubMed ID: 16158196
[TBL] [Abstract][Full Text] [Related]
11. Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase.
Cocchiarella F; Latella MC; Basile V; Miselli F; Galla M; Imbriano C; Recchia A
Mol Ther Methods Clin Dev; 2016; 3():16038. PubMed ID: 27574698
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells.
Yant SR; Park J; Huang Y; Mikkelsen JG; Kay MA
Mol Cell Biol; 2004 Oct; 24(20):9239-47. PubMed ID: 15456893
[TBL] [Abstract][Full Text] [Related]
13. Hyperactive Himar1 transposase mediates transposition in cell culture and enhances gene expression in vivo.
Keravala A; Liu D; Lechman ER; Wolfe D; Nash JA; Lampe DJ; Robbins PD
Hum Gene Ther; 2006 Oct; 17(10):1006-18. PubMed ID: 16989604
[TBL] [Abstract][Full Text] [Related]
14. RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues.
Wilber A; Frandsen JL; Geurts JL; Largaespada DA; Hackett PB; McIvor RS
Mol Ther; 2006 Mar; 13(3):625-30. PubMed ID: 16368272
[TBL] [Abstract][Full Text] [Related]
15. Extending the transposable payload limit of Sleeping Beauty (SB) using the Herpes Simplex Virus (HSV)/SB amplicon-vector platform.
de Silva S; Mastrangelo MA; Lotta LT; Burris CA; Federoff HJ; Bowers WJ
Gene Ther; 2010 Mar; 17(3):424-31. PubMed ID: 19865178
[TBL] [Abstract][Full Text] [Related]
16. A highly soluble Sleeping Beauty transposase improves control of gene insertion.
Querques I; Mades A; Zuliani C; Miskey C; Alb M; Grueso E; Machwirth M; Rausch T; Einsele H; Ivics Z; Hudecek M; Barabas O
Nat Biotechnol; 2019 Dec; 37(12):1502-1512. PubMed ID: 31685959
[TBL] [Abstract][Full Text] [Related]
17.
Kovač A; Miskey C; Ivics Z
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834425
[TBL] [Abstract][Full Text] [Related]
18. Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.
Mikkelsen JG; Yant SR; Meuse L; Huang Z; Xu H; Kay MA
Mol Ther; 2003 Oct; 8(4):654-65. PubMed ID: 14529839
[TBL] [Abstract][Full Text] [Related]
19. Integration profile and safety of an adenovirus hybrid-vector utilizing hyperactive sleeping beauty transposase for somatic integration.
Zhang W; Muck-Hausl M; Wang J; Sun C; Gebbing M; Miskey C; Ivics Z; Izsvak Z; Ehrhardt A
PLoS One; 2013; 8(10):e75344. PubMed ID: 24124483
[TBL] [Abstract][Full Text] [Related]
20. Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates.
Mátés L; Chuah MK; Belay E; Jerchow B; Manoj N; Acosta-Sanchez A; Grzela DP; Schmitt A; Becker K; Matrai J; Ma L; Samara-Kuko E; Gysemans C; Pryputniewicz D; Miskey C; Fletcher B; VandenDriessche T; Ivics Z; Izsvák Z
Nat Genet; 2009 Jun; 41(6):753-61. PubMed ID: 19412179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
